Director, Translational Medicine Expert (Neurodegeneration)

Job Description Summary

#LI-Hybrid

Internal Title: Director

Location: Cambridge, MA, USA

The Director, Translational Medicine Expert (Neurodegeneration) will lead the end to end translational strategy for neurodegenerative programs, bridging preclinical research to early clinical development (Phase 1–2).

This role is accountable for biomarker strategy, clinical endpoint selection, and early phase trial design, enabling efficient, data driven decision-making through key development milestones (e.g., Transition Decision Points) and ensuring competitive differentiation of neuromuscular assets.

In addition, he/she oversees the planning, execution, and interpretation of clinical trials research, data collection activities and clinical operations. Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems and final reports. Support new and ongoing clinical research and clinical trials and ensure efficient and timely processing of confidentiality agreements and clinical agreements

Essential Requirements:

· MD, neurologists, clinical training in neurodegenerative diseases

· Experience in translational medicine, early clinical development, or experimental therapeutics.

· Ability to shape development strategies, execute early clinical studies, and influence regulatory/packages supporting differentiation.

Desirable Requirements:

· Experience working in pharmaceutical/biotech company strongly preferred.

· PhD, PharmD, or equivalent in:

o Neurology / Neuroscience

o Neurodegenerative diseases

The salary for this position is expected to range between: $248,500--$461,500/year

The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors. Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.

US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.

Skills Desired

Clinical Trials, Data Analysis, Data Monitoring, Drug Development, Medical Research, People Management

Salary Range

$248,500.00 - $461,500.00

EEO Statement:

The Novartis Group of Companies are Equal Opportunity Employers. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. We strive to create an inclusive workplace that cultivates bold innovation through collaboration and empowers our people to unleash their full potential.

Accessibility and reasonable accommodations

The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or in order to perform the essential functions of a position, please send an e-mail to tas.nacomms@novartis.com call +1 (877)395-2339 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.

https://www.novartis.com/careers/careers-research/notice-all-applicants-us-job-openings

Band

Level 6

1. Translational Strategy & Program Leadership

• Define and execute integrated translational strategies across neurodegeneration programsLead translational components from preclinical → Phase 1/2 clinical studiesDrive program progression through key decision gates (e.g., IND, TDP, IDPA)Ensure strong mechanistic linkage between target biology, biomarkers, and clinical endpoints

2. Biomarker & Endpoint Leadership

• Collaborate with Biomarker Development colleagues toward development and validation of:Molecular biomarkers (tissue, blood, CSF where applicable)Functional endpoints (strength, mobility, disease-specific measures)Patient-reported outcomes (PROs)Establishing quantitative biomarkers to support:Target engagementDisease modificationDose selection and PoC decisionsIntegrate biomarker strategy into clinical protocols and operational plansDrive early biomarker de‑risking, a key priority in neuromuscular programs

3. Early Clinical Development (Phase 1/2)

• Co‑lead design and execution of early clinical studiesDefine:Dose escalation strategyExposure–response frameworkTranslational endpoints (biopsy, imaging, functional)Ensure TM leadership within Clinical Trial Teams (CTTs) for:Trial designExecution oversightData interpretation and decision-making

4. Cross-Functional Leadership

• Serve as core Translational Medicine representative within global project teamsPartner closely with:Clinical DevelopmentBiomarker DevelopmentClinical Pharmacology (PKS)Preclinical Safety (PCS)RegulatoryDrive alignment between research, TM, and development organizations

5. External Scientific Leadership

• Build and lead collaborations with:Academic KOLsPatient advocacy groups (critical in rare neuromuscular disease)Technology partners (imaging, omics platforms)Contribute to scientific strategy and external positioning of programs

6. Patient-Centered Development

• Integrate the patient voice into translational and clinical strategiesAdvance:Meaningful functional endpointsPatient-relevant outcome measuresInnovative trial approaches (e.g., decentralized models where feasible)

7. Portfolio Contribution & Strategic Input

• Contribute to:Asset prioritization and portfolio strategyCompetitive differentiation strategy (e.g., vs RNA or gene therapy competitors)Provide scientific input to:Business development / due diligenceIndication expansion strategies